Wyoming Multistate
Pharmacy
Jurisprudence Exam
2025/2026
Question 1
According to the Wyoming Pharmacy Act, what is the short title of W.S. 33-24-101 through 33-
24-301? A. Wyoming Controlled Substances Act B. Wyoming Pharmacy Act C. Wyoming Drug
Identification Act D. Wyoming Compounding Regulations Act
Rationale: The Wyoming Pharmacy Act is defined in W.S. 33-24-101(a) as encompassing
sections 33-24-101 through 33-24-301, establishing the framework for pharmacy practice
regulation in the state.
Question 2
Which of the following is required for a pharmacist to obtain an initial license in Wyoming as of
2025? A. Completion of 1,500 hours of internship B. Graduation from an ACPE-accredited
pharmacy program and passing NAPLEX/MPJE C. Two years of practical experience D. High
school diploma and 6 months training
Rationale: Wyoming licensure requires graduation from an ACPE-accredited program, 1,200
internship hours, and passing NABP exams (NAPLEX and MPJE), per W.S. 33-24-116 and
Board rules Chapter 2.
Question 3
Under Wyoming law, who is responsible for the practice of pharmacy in a licensed facility? A.
Pharmacy technician B. Physician C. Pharmacist-in-charge D. Facility owner
Rationale: The pharmacist-in-charge is responsible for all pharmacy activities, including
compliance with laws, as outlined in W.S. 33-24-133 and Board rules Chapter 2, Section 2-4.
,Question 4
What is the renewal period for individual controlled substance registrations in Wyoming for
2025-2027? A. Annually B. Biennially C. Triennially D. Every 5 years
Rationale: Individual controlled substance registrations renew every two years, expiring June
30, as per Wyoming Board of Pharmacy guidelines and W.S. 35-7-1033.
Question 5
According to HB0164 (2025), which action is now authorized for pharmacists regarding off -
label indications? A. Prescribing controlled substances B. Dispensing medications for off-label
use as prescribed C. Compounding off-label products without prescription D. Importing off-label
drugs
Rationale: HB0164 authorizes prescribers to prescribe off-label and pharmacists to dispense
such medications, effective July 1, 2025, amending the Wyoming Pharmacy Act to align with
federal standards.
Question 6
In Wyoming, what schedules of controlled substances must be reported to the PDMP by retail
pharmacies? A. Schedule I only B. Schedules I and II C. Schedules II-V D. All schedules I-V
Rationale: The Wyoming PDMP requires reporting of Schedule II-V controlled substance
prescriptions dispensed to residents, per Board rules and W.S. 35-7-1060.
Question 7
Under DEA regulations effective 2025, what is required for telemedicine prescribing of Schedule
III-V controlled substances? A. In-person exam every 6 months B. No in-person exam required if
using approved telemedicine platform C. Written consent from patient D. Prior authorization
from state board
Rationale: DEA's new telemedicine rules allow prescribing Schedule III-V controlled
substances via telehealth without an in-person exam if compliant with established protocols,
effective March 2025.
Question 8
What is the minimum continuing education requirement for Wyoming pharmacists renewing by
December 31, 2025? A. 6 hours B. 12 hours C. 20 hours D. 30 hours
Rationale: Per W.S. 33-24-121, pharmacists must complete 12 hours of approved CPE annually,
reported by December 31.
, Question 9
According to the Wyoming Controlled Substances Act, which schedule includes preparations
with limited quantities of narcotics? A. Schedule I B. Schedule II C. Schedule V D. Schedule III
Rationale: Schedule V consists of preparations containing limited quantities of narcotics or
other controlled substances, per W.S. 35-7-1022 and aligned with federal definitions.
Question 10
Who must register with the Wyoming Board of Pharmacy for a controlled substance registration
as of 2025? A. Only manufacturers B. Dispensers and practitioners dispensing to patients C.
Wholesalers only D. Hospitals exclusively
Rationale: Dispensers, including practitioners who dispense controlled substances, must obtain a
Wyoming CSR, per W.S. 35-7-1024 and Board rules.
Question 11
Under NABP's MPJE content outline for 2025, what percentage of the exam covers state-specific
laws? A. 20% B. 50% C. 70% D. 85%
Rationale: The MPJE allocates approximately 50% to state/jurisdiction-specific laws and 50%
to federal, per NABP's content outline.
Question 12
What is the penalty for unlawful possession of a controlled substance in Wyoming under W.S.
35-7-1031? A. Civil fine only B. Misdemeanor or felony depending on substance and amount C.
Mandatory community service D. License revocation only
Rationale: Unlawful possession is a misdemeanor or felony based on the controlled substance
and quantity, per W.S. 35-7-1031.
Question 13
As of 2025, are prescribers required to check the Wyoming PDMP before prescribing controlled
substances? A. No B. Yes, for initial and subsequent prescriptions C. Only for Schedule II D.
Annually only
Rationale: Prescribers must query the PDMP before prescribing Schedule II-V controlled
substances, per state law and Board rules.
Question 14
Pharmacy
Jurisprudence Exam
2025/2026
Question 1
According to the Wyoming Pharmacy Act, what is the short title of W.S. 33-24-101 through 33-
24-301? A. Wyoming Controlled Substances Act B. Wyoming Pharmacy Act C. Wyoming Drug
Identification Act D. Wyoming Compounding Regulations Act
Rationale: The Wyoming Pharmacy Act is defined in W.S. 33-24-101(a) as encompassing
sections 33-24-101 through 33-24-301, establishing the framework for pharmacy practice
regulation in the state.
Question 2
Which of the following is required for a pharmacist to obtain an initial license in Wyoming as of
2025? A. Completion of 1,500 hours of internship B. Graduation from an ACPE-accredited
pharmacy program and passing NAPLEX/MPJE C. Two years of practical experience D. High
school diploma and 6 months training
Rationale: Wyoming licensure requires graduation from an ACPE-accredited program, 1,200
internship hours, and passing NABP exams (NAPLEX and MPJE), per W.S. 33-24-116 and
Board rules Chapter 2.
Question 3
Under Wyoming law, who is responsible for the practice of pharmacy in a licensed facility? A.
Pharmacy technician B. Physician C. Pharmacist-in-charge D. Facility owner
Rationale: The pharmacist-in-charge is responsible for all pharmacy activities, including
compliance with laws, as outlined in W.S. 33-24-133 and Board rules Chapter 2, Section 2-4.
,Question 4
What is the renewal period for individual controlled substance registrations in Wyoming for
2025-2027? A. Annually B. Biennially C. Triennially D. Every 5 years
Rationale: Individual controlled substance registrations renew every two years, expiring June
30, as per Wyoming Board of Pharmacy guidelines and W.S. 35-7-1033.
Question 5
According to HB0164 (2025), which action is now authorized for pharmacists regarding off -
label indications? A. Prescribing controlled substances B. Dispensing medications for off-label
use as prescribed C. Compounding off-label products without prescription D. Importing off-label
drugs
Rationale: HB0164 authorizes prescribers to prescribe off-label and pharmacists to dispense
such medications, effective July 1, 2025, amending the Wyoming Pharmacy Act to align with
federal standards.
Question 6
In Wyoming, what schedules of controlled substances must be reported to the PDMP by retail
pharmacies? A. Schedule I only B. Schedules I and II C. Schedules II-V D. All schedules I-V
Rationale: The Wyoming PDMP requires reporting of Schedule II-V controlled substance
prescriptions dispensed to residents, per Board rules and W.S. 35-7-1060.
Question 7
Under DEA regulations effective 2025, what is required for telemedicine prescribing of Schedule
III-V controlled substances? A. In-person exam every 6 months B. No in-person exam required if
using approved telemedicine platform C. Written consent from patient D. Prior authorization
from state board
Rationale: DEA's new telemedicine rules allow prescribing Schedule III-V controlled
substances via telehealth without an in-person exam if compliant with established protocols,
effective March 2025.
Question 8
What is the minimum continuing education requirement for Wyoming pharmacists renewing by
December 31, 2025? A. 6 hours B. 12 hours C. 20 hours D. 30 hours
Rationale: Per W.S. 33-24-121, pharmacists must complete 12 hours of approved CPE annually,
reported by December 31.
, Question 9
According to the Wyoming Controlled Substances Act, which schedule includes preparations
with limited quantities of narcotics? A. Schedule I B. Schedule II C. Schedule V D. Schedule III
Rationale: Schedule V consists of preparations containing limited quantities of narcotics or
other controlled substances, per W.S. 35-7-1022 and aligned with federal definitions.
Question 10
Who must register with the Wyoming Board of Pharmacy for a controlled substance registration
as of 2025? A. Only manufacturers B. Dispensers and practitioners dispensing to patients C.
Wholesalers only D. Hospitals exclusively
Rationale: Dispensers, including practitioners who dispense controlled substances, must obtain a
Wyoming CSR, per W.S. 35-7-1024 and Board rules.
Question 11
Under NABP's MPJE content outline for 2025, what percentage of the exam covers state-specific
laws? A. 20% B. 50% C. 70% D. 85%
Rationale: The MPJE allocates approximately 50% to state/jurisdiction-specific laws and 50%
to federal, per NABP's content outline.
Question 12
What is the penalty for unlawful possession of a controlled substance in Wyoming under W.S.
35-7-1031? A. Civil fine only B. Misdemeanor or felony depending on substance and amount C.
Mandatory community service D. License revocation only
Rationale: Unlawful possession is a misdemeanor or felony based on the controlled substance
and quantity, per W.S. 35-7-1031.
Question 13
As of 2025, are prescribers required to check the Wyoming PDMP before prescribing controlled
substances? A. No B. Yes, for initial and subsequent prescriptions C. Only for Schedule II D.
Annually only
Rationale: Prescribers must query the PDMP before prescribing Schedule II-V controlled
substances, per state law and Board rules.
Question 14
